DUSP2.md
... ...
@@ -35,13 +35,8 @@ timeline
35 35
36 36
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
37 37
38
-|Entity|source |frequency (%)|
39
-|:------:|:--------------:|:-------------:|
40
-|DLBCL |GAMBL genomes |10.13 |
41
-|DLBCL |Schmitz cohort|12.55 |
42
-|DLBCL |Reddy cohort | 9.71 |
43
-|DLBCL |Chapuy cohort | 4.27 |
44
-|FL |GAMBL genomes | 2.31 |
38
+[[include:DLBCL_DUSP2.md]]
39
+[[include:FL_DUSP2.md]]
45 40
46 41
## Mutation pattern and selective pressure estimates
47 42
EBF1.md
... ...
@@ -36,16 +36,8 @@ timeline
36 36
37 37
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
38 38
39
-|Entity|source |frequency (%)|
40
-|:------:|:---------------------:|:-------------:|
41
-|BL |GAMBL genomes+capture| 2.08 |
42
-|BL |Thomas cohort | 1.30 |
43
-|BL |Panea cohort | 5.90 |
44
-|DLBCL |GAMBL genomes | 8.99 |
45
-|DLBCL |Schmitz cohort |10.85 |
46
-|DLBCL |Reddy cohort | 8.81 |
47
-|DLBCL |Chapuy cohort |12.82 |
48
-|FL |GAMBL genomes | 8.55 |
39
+[[include:DLBCL_EBF1.md]]
40
+[[include:FL_EBF1.md]]
49 41
50 42
## Mutation pattern and selective pressure estimates
51 43